Inge O. Baas

2.1k citations
42 papers · 1.4k · h-index 17

Impact in

Papers in

  • Oncology 15
    • Cancer-related Molecular Pathways 6
    • COVID-19 and healthcare impacts 5
  • Cancer Research 8
    • Breast Cancer Treatment Studies 6
Co-authors
G. Johan A. Offerhaus (7 shared papers)Stanley R. Hamilton (2 shared papers)Jan‐Willem R. Mulder (2 shared papers)Bert Vogelstein (1 shared paper)William H. Westra (2 shared papers)Robert J.C. Slebos (2 shared papers)Frank M. van den Berg (3 shared papers)G. J. A. Offerhaus (3 shared papers)
Journals
Breast Cancer Research and Treatment (6 papers)Journal of Clinical Pathology (2 papers)The Journal of Pathology (2 papers)International Journal of Cancer (2 papers)Human Pathology (2 papers)
Partner nations
NetherlandsUnited StatesSwitzerland

In The Last Decade

Inge O. Baas

42 papers receiving 1.4k citations

Peers

Inge O. Baas
Comparison fields: 5 of 94
  • Oncology 597
  • Pathology and Forensic Medicine 248
  • Cancer Research 190
  • Pulmonary and Respiratory Medicine 312
  • Biotechnology 69
Replace Albiruni Ryan Abdul Razak with:
Albiruni Ryan Abdul Razak Canada
Emilia Cocorocchio Italy
Jianling Yuan United States
Tong-Yu Lin China
Fabio Conforti Italy
S. David Nathanson United States
Jacob R. Izbicki Germany
Mauro Signorelli Italy
Katy K. Tsai United States
Ruby Phelps United States
Inge O. Baas relative to Albiruni Ryan Abdul Razak Canada Albiruni Ryan Abdul Razak's profile →
Citations per field
00.5×2×3.3×
Albiruni Ryan Abdul Razak · 1×
Citations per year

Countries citing papers authored by Inge O. Baas

Since Specialization
Citations

This map shows the geographic impact of Inge O. Baas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge O. Baas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge O. Baas more than expected).

Fields of papers citing papers by Inge O. Baas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge O. Baas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge O. Baas. The network helps show where Inge O. Baas may publish in the future.

Co-authors

The 25 scholars most cited alongside Inge O. Baas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Inge O. Baas Line = papers co-authored together Inge O. Baas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1
An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms
The Journal of Pathology ·Inge O. Baas, Jan‐Willem R. Mulder, G. Johan A. Offerhaus, Bert Vogelstein, Stanley R. Hamilton
1994469
2
K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.
PubMed ·William H. Westra, Inge O. Baas, R.H. Hruban, Fredric B Askin, K Wilson, G. J. A. Offerhaus, Robert J.C. Slebos
1996190
3
Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid.
PubMed ·Frank M. van den Berg, Inge O. Baas, M Polák, G. Johan A. Offerhaus
199395
4
Overexpression of the p53 Tumor Suppressor Gene Product in Primary Lung Adenocarcinomas Is Associated with Cigarette Smoking
The American Journal of Surgical Pathology ·William H. Westra, G.J.A. Offerhaus, Steven N. Goodman, Robert J.C. Slebos, Miriam Polak, Inge O. Baas, Sjoerd Rodenhuis, Ralph H. Hruban
199383
5
Impact of the COVID-19 Pandemic on Patient-Reported Outcomes of Breast Cancer Patients and Survivors
JNCI Cancer Spectrum ·Claudia A. Bargon, Marilot C. T. Batenburg, Lilianne E. van Stam, Dieuwke R. Mink van der Molen, Iris E. van Dam, Femke van der Leij, Inge O. Baas, Miranda F. Ernst, Wiesje Maarse, Nieke Vermulst, Ernst J. P. Schoenmaeckers, Thijs van Dalen, Rhodé M. Bijlsma, Danny A. Young‐Afat, Annemiek Doeksen, Helena M. Verkooijen
202061
6
p53 alterations in atypical alveolar hyperplasia of the human lung
Human Pathology ·Robbert J.C. Slebos, Inge O. Baas, Marjon J. Clement, G. Johan A. Offerhaus, Fredric B Askin, Ralph H. Hruban, William H. Westra
199861
7
POTENTIAL FALSE‐POSITIVE RESULTS WITH ANTIGEN ENHANCEMENT FOR IMMUNOHISTOCHEMISTRY OF THE p53 GENE PRODUCT IN COLORECTAL NEOPLASMS
The Journal of Pathology ·Inge O. Baas, Frank M. van den Berg, Jan‐Willem R. Mulder, Marjon J. Clement, Robbert J.C. Slebos, Stanley R. Hamilton, G. Johan A. Offerhaus
199646
8
Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach.
Journal of Clinical Pathology ·Inge O. Baas, Bastiaan P. van Rees, Alex R. Musler, M. E. Craanen, G. N. J. Tytgat, Frank M. van den Berg, G. Johan A. Offerhaus
199845
9
c-Myb Regulates the T-Bet-Dependent Differentiation Program in B Cells to Coordinate Antibody Responses
Cell Reports ·Dana Piovesan, Jessica C. Tempany, Andrea Di Pietro, Inge O. Baas, Callisthenis Yiannis, Kristy O’Donnell, Yunshun Chen, Victor Peperzak, Gabrielle T. Belz, Charles R. Mackay, Gordon K. Smyth, Joanna R. Groom, David M. Tarlinton, Kim L. Good‐Jacobson
201744
10
α-Interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease
Biology of Blood and Marrow Transplantation ·Eduardus F. M. Posthuma, Erik W.A. Marijt, Renée M. Y. Barge, Ronald A van Soest, Inge O. Baas, C.W.J. Starrenburg, Shama L. van Zelderen‐Bhola, Willem E. Fibbe, W. M. Smit, Roel Willemze, J.H. Frederik Falkenburg
200436
11
Alterations of thep53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence area
International Journal of Cancer ·Patrick Sturm, Inge O. Baas, Marjon J. Clement, Attila Nakeeb, G. J. A. Offerhaus, Ralph H. Hruban, Henry A. Pitt
199830
12
The impact of the COVID-19 pandemic on quality of life, physical and psychosocial wellbeing in breast cancer patients – a prospective, multicenter cohort study
European Journal of Cancer ·Claudia A. Bargon, Marilot C. T. Batenburg, L. van Stam, D. Mink van der Molen, Iris van Dam, Feike R. van der Leij, Inge O. Baas, M.F. Ernst, Wiesje Maarse, Nieke Vermulst, Ernst J. P. Schoenmaeckers, Thijs van Dalen, Rhodé M. Bijlsma, Danny A. Young‐Afat, Annemiek Doeksen, Helena M. Verkooijen
202023
13
Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires Rac-mediated interaction with stromal cells
Experimental Hematology ·Marjan Rozenveld-Geugien, Inge O. Baas, Djoke van Gosliga, Edo Vellenga, Jan Jacob Schuringa
200721
14
Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands
Breast Cancer Research and Treatment ·Carmen van Dooijeweert, Ivette A.G. Deckers, Inge O. Baas, Elsken van der Wall, P. J. van Diest
201919
15
Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): Patient Characteristics, Treatment, and Outcome—A Systematic Review
Cancers ·Francis S. P. L. Wens, Caroline C. C. Hulsker, Marta Fiocco, József Zsíros, Stephanie E. Smetsers, Ronald R. de Krijger, Alida F. W. van der Steeg, Ronald P. Zweemer, Inge O. Baas, Eva Maria Roes, Leendert H. J. Looijenga, Cornelis G. Gerestein, Annelies M. C. Mavinkurve‐Groothuis
202318
16
Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cells
Haematologica ·Inge O. Baas, Laura Delvasto-Núñez, Peter C. Ligthart, Conny Brouwer, Claudia C. Folman, Edimara S. Reis, Daniel Ricklin, John D. Lambris, Diana Wouters, Masja de Haas, Ilse Jongerius, Sacha Zeerleder
201917
17
The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients
Breast Cancer Research and Treatment ·(unknown), M.L. Gregorowitsch, A. Ghedri, Danny A. Young‐Afat, Rhodé M. Bijlsma, Inge O. Baas, Christa van Schaik-van de Mheen, Mariëtte J Agterof, Emine Göker, Daan ten Bokkel Huinink, H.J.G.D. van den Bongard, Helena M. Verkooijen
201916
18
Immunotherapy for Gestational Trophoblastic Neoplasia: A New Paradigm
Gynecologic and Obstetric Investigation ·Inge O. Baas, Anneke M. Westermann, Benoît You, Pierre-Adrien Bolze, Michael J. Seckl, Ehsan Ghorani
202315
19
First-time imaging of [89Zr]trastuzumab in breast cancer using a long axial field-of-view PET/CT scanner
European Journal of Nuclear Medicine and Molecular Imaging ·Adrienne H. Brouwers, Joyce van Sluis, Johannes H. van Snick, Carolina P. Schröder, Inge O. Baas, Ronald Boellaard, Andor W.J.M. Glaudemans, Ronald Borra, Adriaan A. Lammertsma, Rudi Dierckx, Charalampos Tsoumpas
202215
20
Self-reported work ability in breast cancer survivors; a prospective cohort study in the Netherlands
The Breast ·M.L. Gregorowitsch, H.J.G.D. van den Bongard, Couwenberg A.M., Danny A. Young‐Afat, Cees Haaring, Thijs van Dalen, Ernst J. P. Schoenmaeckers, Mariëtte J Agterof, Inge O. Baas, S F, E. Moussa Yagata F., Ragna van Hummel, Helena M. Verkooijen
201914

About Inge O. Baas

Inge O. Baas is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Hematology, having authored 42 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Breast Cancer Treatment Studies (6 papers), COVID-19 and healthcare impacts (5 papers), Blood groups and transfusion (4 papers), Erythrocyte Function and Pathophysiology (4 papers), Complement system in diseases (3 papers), Cancer-related cognitive impairment studies (2 papers) and Blood transfusion and management (2 papers). The work is most often cited by research in Oncology (597 citations), Pathology and Forensic Medicine (248 citations), Cancer Research (190 citations), Pulmonary and Respiratory Medicine (312 citations) and Biotechnology (69 citations). Inge O. Baas has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include G. Johan A. Offerhaus, Stanley R. Hamilton, Jan‐Willem R. Mulder, Bert Vogelstein, William H. Westra, Robert J.C. Slebos, Frank M. van den Berg, G. J. A. Offerhaus, R.H. Hruban and M Polák. Their work appears in journals such as Breast Cancer Research and Treatment, Journal of Clinical Pathology, The Journal of Pathology, International Journal of Cancer and Human Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Albiruni Ryan Abdul RazakBreakdown of academic impact, for papers by Emilia CocorocchioBreakdown of academic impact, for papers by Jianling YuanBreakdown of academic impact, for papers by Tong-Yu LinBreakdown of academic impact, for papers by Fabio ConfortiBreakdown of academic impact, for papers by S. David NathansonBreakdown of academic impact, for papers by Jacob R. IzbickiBreakdown of academic impact, for papers by Mauro SignorelliBreakdown of academic impact, for papers by Katy K. TsaiBreakdown of academic impact, for papers by Ruby Phelps